© 2003 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
Characterisation of the Na, K pump current in atrial cells from patients with and without chronic atrial fibrillation
aSection of Cardiology, Division of Cardiovascular & Medical Sciences, University of Glasgow, Royal Infirmary, Glasgow G31 2ER, UK
bDepartment of Physiology and Pharmacology, University of Strathclyde, Glasgow G4 ONR, UK
a.j.workman{at}clinmed.gla.ac.uk
* Corresponding author. Tel.: +44-141-211-1231; fax: +44-141-552-4683.
Objective: To assess the contribution of the Na, K pump current (Ip) to the action potential duration (APD) and effective refractory period (ERP) in human atrial cells, and to investigate whether Ip contributes to the changes in APD and ERP associated with chronic atrial fibrillation (AF). Methods: Action potentials and ion currents were recorded by whole-cell patch clamp in atrial myocytes isolated from consenting patients undergoing cardiac surgery, who were in sinus rhythm (SR) or AF (>3 months). Results: In cells from patients in SR, the Ip blocker, ouabain (10 µM) significantly depolarised the membrane potential, Vm, from –80±2 (mean±S.E.) to –73±2 mV, and lengthened both the APD (174±17 vs. 197±23 ms at 90% repolarisation) and ERP (198±22 vs. 266±14 ms; P<0.05 for each, Student’s t-test, n=7 cells, 5 patients). With an elevated pipette [Na+] of 30 mM, Ip was measured by increasing extracellular [K+] ([K+]o) from 0 to 5.4 mM. This produced an outward shift in holding current at –40 mV, abolished by 10 µM ouabain. K+- and ouabain-sensitive current densities were similar, at 0.99±0.13 and 1.12±0.11 pA/pF, respectively (P>0.05; n=9 cells), confirming the K+-induced current as Ip. Ip increased linearly with increasing Vm between –120 and +60 mV (n=25 cells). Stepwise increments in [K+]o (between 0 and 10 mM) increased Ip in a concentration-dependent manner (maximum response, Emax=1.19±0.09 pA/pF; EC50=1.71±0.15 mM; n=27 cells, 9 patients). In cells from patients in AF, the sensitivity of Ip to both Vm and [K+]o (Emax=1.02±0.05 pA/pF, EC50=1.54±0.11 mM; n=44 cells, 9 patients) was not significantly different from that in cells from patients in SR. Within the group of patients in AF, long-term digoxin therapy (n=5 patients) was associated with a small, but significant, reduction in Emax (0.92±0.07 pA/pF) and EC50 (1.35±0.15 mM) compared with non-treatment (Emax=1.13±0.08 pA/pF, EC50=1.76±0.14 mM; P<0.05 for each, n=4 patients). In cells from non-digoxin-treated patients in AF, the voltage- and [K+]o-sensitivity (Emax and EC50) were similar to those in cells from patients in SR. Conclusions: The Na, K pump current contributes to the human atrial cell Vm, action potential shape and ERP. However, the similarity in Ip sensitivity to both [K+]o and Vm between atrial cells from patients with and without chronic AF indicates that Ip is not involved in AF-induced electrophysiological remodelling in patients.
KEYWORDS Na/K-pump; Membrane currents; Atrial function; Arrhythmia (mechanisms); Remodelling
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. J. Benjamin, P.-S. Chen, D. E. Bild, A. M. Mascette, C. M. Albert, A. Alonso, H. Calkins, S. J. Connolly, A. B. Curtis, D. Darbar, et al. Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop Circulation, February 3, 2009; 119(4): 606 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Narayan, D. Kazi, D. E. Krummen, and W.-J. Rappel Repolarization and Activation Restitution Near Human Pulmonary Veins and Atrial Fibrillation Initiation: A Mechanism for the Initiation of Atrial Fibrillation by Premature Beats J. Am. Coll. Cardiol., October 7, 2008; 52(15): 1222 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C R Liu, L Y Li, F Shi, X Y Zang, Y M Liu, Y Sun, and B H Kan Effects of hyper- and hypothyroid on expression of thyroid hormone receptor mRNA in rat myocardium J. Endocrinol., December 1, 2007; 195(3): 429 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhang, C. J. Garratt, J. Zhu, and A. V. Holden Role of up-regulation of IK1 in action potential shortening associated with atrial fibrillation in humans Cardiovasc Res, June 1, 2005; 66(3): 493 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Carmeliet Does the Na+,K+ pump current undergo remodeling in atrial fibrillation? Cardiovasc Res, September 1, 2003; 59(3): 536 - 537. [Full Text] [PDF]
|
|